Literature DB >> 10689872

A new operation for noncorrectable biliary atresia.

H Ando1.   

Abstract

An improved operative technique to transect the fibrous cord by dividing the ligamentum venosum (Arantius' canal) is described for noncorrectable biliary atresia. The Arantius' canal is situated cranial and posterior side to the bifurcation of the umbilical portion and the portal branch of the Quinous' segment 3. The portal vein is fully mobile and the porta hepatis can be widely exposed by dividing the Arantius' canal. The fibrous cord of the porta hepatis can easily be dissected posteriorly and laterally where there is an extensive number of bile ducts. Eight patients with biliary atresia underwent this procedure. Jaundice resolved completely (serum total bilirubin concentration: < or = 1 mg/dl) in 7 patients within 40 days. Postoperative cholangitis did not occur. By dividing the Arantius' canal, the portal vein comes free from the portal fissure to make the hepatic hilum wider, and surgeons are able to work within a larger porta hepatic space without causing portal vein compression. Free drainage of the bile from the porta hepatis may prevent postoperative cholangitis and promote resolution of jaundice.

Entities:  

Mesh:

Year:  1999        PMID: 10689872

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  3 in total

1.  Portoenterostomy as a Salvage Procedure for Major Biliary Complications Following Hepaticojejunostomy.

Authors:  Amit Sharma; John S Hammond; Emmanouil Psaltis; W Keith Dunn; Dileep N Lobo
Journal:  J Gastrointest Surg       Date:  2017-02-08       Impact factor: 3.452

Review 2.  Biliary atresia: unity in diversity.

Authors:  Claus Petersen
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

3.  <Editors' Choice> Long-term outcomes of the partial splenectomy for hypersplenism after portoenterostomy of patients with biliary atresia.

Authors:  Takahisa Tainaka; Akinari Hinoki; Yujiro Tanaka; Chiyoe Shirota; Wataru Sumida; Kazuki Yokota; Satoshi Makita; Kazuo Oshima; Hizuru Amano; Aitaro Takimoto; Yoko Kano; Hiroo Uchida
Journal:  Nagoya J Med Sci       Date:  2021-11       Impact factor: 1.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.